09/17/2025 - USA | DC | DISTRICT OF COLUMBIA COUNTY | WASHINGTON | 20814
Health And Human Services, Department Of- National Institutes Of Health- Nih National Cancer Institute
Biospecimen Collection
Resource for the Collection of Patient Human Tissue, Cells and Biofluids from Cancer Donors, High- Risk Patients, and Healthy Population Controls with an Epidemiologic Profile and Reportable Database - This contract supports clinical research studies, including natural history studies at NIH- funded institutions. The purpose of this modification action is to add two- 12- month option periods to contract # **** which ends on
Research Development ( RD) support services for clinical research studies, including natural history studies at NIH funded institutions.
AI helper
This is a request for continuation of a research contract with the University of Maryland Medical Center. The contract involves collecting and analyzing patient data, biospecimens, and epidemiological data for research on human carcinogenesis. The current contractor has a long history of successful performance, including IRB approvals from two hospitals (University of Maryland Medical Center and the Veterans Affairs Hospital). The notice details the need for a continuation of the contract, emphasizing the importance of maintaining the existing data collection infrastructure and the unique expertise of the current contractor. The contract has been ongoing for almost 30 years, and the data collected is crucial for ongoing research. A sources sought notice was posted on SAM. gov, but no suitable alternative contractors were found. The contracting officer will conduct a cost analysis and cost realism analysis as part of the award decision. The modification action is to add two 12-month option periods to the existing contract, increasing the total estimated contract value.
The notice states that the University of Maryland has unique qualifications in patient recruitment, maintaining longitudinal records, and supporting clinical research studies. he university's expertise in patient recruitment and in maintaining detailed longitudinal records with followup data makes it unique, not only in sustaining the viability and relevance of studies for decades, but also as the only institution that developed a dedicated mechanism to support these clinical research studies.
A site visit has been conducted. as approved in the last site visit.
The notice states that the proposed action will increase the total estimated contract value. he proposed action will increase the total estimated contract value.
